GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LigaChem Biosciences 141080.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

56,800

-2.74%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩141.55bn

FY2016FY2025

Net income

−₩74.28bn

FY2016FY2025

Free cash flow

−₩130.57bn

FY2016FY2025

Shareholders' equity

₩507.61bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩141.55bn₩125.90bn₩34.15bn₩33.41bn₩32.16bn₩49.39bn₩57.50bn₩25.24bn₩22.06bn₩16.66bn
Research and development₩216.91bn₩113.19bn₩79.61bn₩51.11bn₩39.07bn₩54.20bn₩16.71bn₩15.51bn₩9.26bn₩7.81bn
Operating income−₩106.49bn−₩20.95bn−₩81.15bn−₩50.61bn−₩26.80bn−₩29.49bn₩8.42bn−₩27.44bn−₩12.71bn−₩14.82bn
Net income−₩74.28bn₩7.80bn−₩73.70bn−₩45.09bn−₩23.39bn−₩6.99bn₩13.59bn−₩25.77bn−₩12.93bn−₩14.72bn
Diluted earnings per share-2,040.31214.99-2,767.92-1,768.10-965.19-294.98633.57-1,216.75-649.63-740.59

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩701.81bn₩738.38bn₩189.50bn₩252.53bn₩293.23bn₩135.91bn₩141.48bn₩121.69bn₩82.24bn₩89.55bn
Cash and short-term investments——₩93.10bn₩62.39bn₩60.44bn₩51.24bn₩42.20bn₩61.70bn₩21.23bn₩30.00bn
Total liabilities₩160.69bn₩122.38bn₩41.28bn₩32.93bn₩34.46bn₩23.79bn₩27.73bn₩20.02bn₩34.03bn₩29.49bn
Debt——₩12.64bn₩12.25bn₩12.27bn₩3.99bn₩2.19bn—₩15.22bn₩14.03bn
Shareholders' equity₩507.61bn₩616.00bn₩148.22bn₩219.60bn₩258.77bn₩112.13bn₩113.75bn₩101.66bn₩48.21bn₩60.06bn
Shares outstanding36m36m27m26m24m24m21m21m20m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩124.53bn₩78.48bn−₩62.24bn−₩7.14bn−₩42.05bn−₩14.89bn₩24.11bn−₩12.76bn−₩8.21bn−₩13.04bn
Capital spending−₩6.04bn−₩5.70bn−₩2.20bn−₩4.16bn−₩18.31bn−₩3.22bn−₩3.37bn−₩3.76bn−₩2.20bn−₩4.24bn
Free cash flow−₩130.57bn₩72.78bn−₩64.44bn−₩11.30bn−₩60.36bn−₩18.11bn₩20.74bn−₩16.51bn−₩10.41bn−₩17.28bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩5.53bn₩35.89bn₩15.95bn₩41.41bn₩32.62bn₩51.58bn₩33.67bn₩30.42bn
Operating income−₩71.98bn−₩37.42bn−₩73.12bn−₩23.20bn−₩21.55bn₩11.38bn−₩13.74bn₩517.0m
Net income−₩71.20bn−₩37.33bn−₩54.57bn−₩15.63bn−₩30.55bn₩26.47bn−₩5.42bn₩11.25bn
Diluted earnings per share-1,953.93-1,024.48-1,497.50-429.34-839.07730.25-149.36307.65
Cash from operations−₩59.51bn−₩46.62bn−₩73.33bn−₩12.15bn−₩8.41bn−₩30.64bn₩78.48bn₩63.92bn
Capital spending−₩1.74bn−₩878.0m−₩1.75bn−₩1.33bn−₩2.22bn−₩735.0m−₩5.70bn−₩3.18bn
Free cash flow−₩61.24bn−₩47.50bn−₩75.09bn−₩13.48bn−₩10.63bn−₩31.37bn₩72.78bn₩60.74bn
Total assets₩594.13bn₩652.93bn₩701.81bn₩699.43bn₩703.69bn₩739.84bn₩738.38bn₩727.15bn
Cash and short-term investments—————₩460.67bn₩483.30bn₩517.55bn
Debt—————₩1.45bn₩339.3m₩12.21bn
Shareholders' equity₩400.15bn₩462.98bn₩507.61bn₩553.89bn₩571.03bn₩583.32bn₩616.00bn₩637.31bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-75.2%-16.6%-237.7%-151.5%-83.3%-59.7%———
Net margin-52.5%6.2%-215.9%-135.0%-72.7%-14.1%———
Return on equity-14.6%1.3%-49.7%-20.5%-9.0%-6.2%———
Return on assets-10.6%1.1%-38.9%-17.9%-8.0%-5.1%———
Free cash flow yield——————1.3%-0.4%-0.3%
Revenue growth12.4%268.7%2.2%3.9%-34.9%-14.1%———
Earnings growth-1052.3%-110.6%63.5%92.8%234.8%-151.4%———
Current ratio8.54x4.70x3.63x6.70x13.45x7.14x———
Debt to equity——0.08x0.01x0.04x0.03x0.02x0.00x—
Equity ratio72.3%83.4%78.2%87.0%88.2%82.5%———
Interest coverage-120.57x-41.63x-153.62x-177.13x-389.69x—326.20x——
R&D as a share of sales153.2%89.9%233.1%153.0%121.5%109.7%———
Buybacks as a share of market value——————-1.2%-6.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue61.8%23.4%54.8%
Operating income28.1%29.3%29.5%
Net income18.1%60.4%24.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-47.6%-77.4%-75.7%-68.6%
Net margin-24.9%-55.3%-51.8%-48.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-85.1—-23.5-24.2-57.8-237.641.7-23.3-31.0-23.9
Price to sales44.731.450.732.742.033.69.823.818.221.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 16 Jun 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.